We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Denosumab improves bone mineral density and microarchitecture in rheumatoid arthritis: randomized controlled trial by HR-pQCT.
- Authors
Chiba, Ko; Iwamoto, Naoki; Watanabe, Kounosuke; Shiraishi, Kazuteru; Saito, Kengo; Okubo, Naoki; Kawakami, Atsushi; Osaki, Makoto
- Abstract
Introduction: This pre-specified exploratory analysis investigated the effect of denosumab on bone mineral density (BMD) and bone microarchitecture in patients with rheumatoid arthritis (RA) treated with conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). Materials and methods: In this open-label, parallel-group study, patients were randomly assigned (1:1) to continuous treatment with csDMARDs plus denosumab or continuous treatment with csDMARD therapy alone for 12 months. BMD and bone microarchitecture were measured by dual-energy X-ray absorptiometry (DXA) and high-resolution peripheral quantitative computed tomography (HR-pQCT). Results: Of 46 patients enrolled in the primary study, 43 were included in the full analysis set. The mean age was 65.3 years, 88.4% were female, and 60.5% had osteoporosis. Areal BMD of the lumbar spine increased from baseline to 6 and 12 months in both groups, but the increase was higher in the csDMARDs plus denosumab group. Areal BMD of the total hip and femoral neck increased from baseline to 6 and 12 months only in the csDMARDs plus denosumab group. Cortical volumetric BMD and cortical thickness of the distal tibia increased in the csDMARDs plus denosumab group at 6 and 12 months but decreased in the csDMARD therapy alone group. Trabecular bone parameters of the distal tibia improved only in the csDMARDs plus denosumab group at 12 months. Conclusion: Denosumab may be recommended for patients with RA treated with csDMARDs to increase BMD and improve bone microarchitecture.
- Subjects
LUMBAR vertebrae; BONE density; RHEUMATOID arthritis; DENOSUMAB; RANDOMIZED controlled trials; DUAL-energy X-ray absorptiometry; CANCELLOUS bone
- Publication
Journal of Bone & Mineral Metabolism, 2023, Vol 41, Issue 6, p797
- ISSN
0914-8779
- Publication type
Article
- DOI
10.1007/s00774-023-01452-9